drugset / Trial / NCT01165866

Ondansetron Versus Metoclopramide in Treatment of Vomiting in Gastroenteritis

NCT01165866

Phase 4 Completed 170 enrolled Hamad Medical Corporation
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Is intravenous metoclopramid as effective as intravenous ondansetron in the treatment of persistent vomiting in patients with acute gastroenteritis.

Timeline

Start
2008-06
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metoclopramide Small molecule 0.3 mg/kg Intravenous
Subject Ondansetron Other / unclassified 0.15 mg/kg Intravenous

Indications